Fumarate of 4-[[4-[[4- (2-cyanoethenyl) - 2,6-dimethylphenyl]amino)-2-pyrimidinyl )amino]benzonitrile

Details for Australian Patent Application No. 2005279157 (hide)

International Classifications

Event Publications

19 April 2007 PCT application entered the National Phase

PCT publication WO2006/024667 Priority application(s): WO2006/024667

2 August 2007 Change of Name(s) of Applicant(s), Section 104

Janssen Pharmaceutica N.V.; Tibotec Pharmaceuticals Ltd. The name of the applicant has been changed to Janssen Pharmaceutica N.V.

9 June 2011 Amendment Made

The nature of the amendment is: Amend the invention title to read Fumarate of 4-[[4-[[4- (2-cyanoethenyl) - 2,6-dimethylphenyl]amino)-2-pyrimidinyl)amino]benzonitrile

14 July 2011 Application Accepted

Published as AU-B-2005279157

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.